Effect of Achieved Systolic Blood Pressure on Cardiovascular Outcomes in Patients With Type 2 Diabetes: A Population-Based Retrospective Cohort Study

被引:28
作者
Wan, Eric Yuk Fai [1 ]
Yu, Esther Yee Tak [1 ]
Chin, Weng Yee [1 ]
Fung, Colman Siu Cheung [1 ]
Fong, Daniel Yee Tak [2 ]
Choi, Edmond Pui Hang [2 ]
Chan, Anca Ka Chun [1 ]
Lam, Cindy Lo Kuen [1 ]
机构
[1] Univ Hong Kong, Dept Family Med & Primary Care, Hong Kong, Hong Kong, Peoples R China
[2] Univ Hong Kong, Sch Nursing, Hong Kong, Hong Kong, Peoples R China
关键词
HEART-DISEASE RISK; MISSING DATA; HYPERTENSIVE PATIENTS; CONTROLLED-TRIALS; MANAGEMENT; IMPUTATION; MORTALITY; STATEMENT; SOCIETY; TARGETS;
D O I
10.2337/dc17-2443
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE The objective of this study was to compare the incidence of cardiovascular disease (CVD) among patients with type 2 diabetes mellitus (T2DM) with treated hypertension who achieved systolic blood pressures (SBPs) of <120, <130, and <140 mmHg after an increase in their antihypertensive regimen. RESEARCH DESIGN AND METHODS A retrospective cohort study was conducted on 28,014 primary care adult patients with T2DM with no prior diagnosis of CVD and who achieved SBP readings <140 mmHg after an increase in the number of antihypertensive medications prescribed. Using an extension of propensity score matching, a total of 2,079, 10,851, and 15,084 matched patients with achieved SBP measurements of <120, <130, and <140 mmHg were identified. The association between achieved SBP and incident CVD were evaluated using Cox regressions. Subgroup analyses were conducted by stratifying patients' baseline characteristics. RESULTS Over a median follow-up period of 4.8 years, the incidence of CVD in patients with achieved SBP measures of <120, <130, and <140 mmHg were 318 (15.3%; incidence rate [IR] 34.3/1,000 person-years [PY]), 992(9.1%; IR 20.4/1,000PY), and 1,635 (10.8%; IR 21.4/1,000 PY). Achieved SBP <120 mmHg was associated with a higher risk of CVD compared with achieved SBP <130 mmHg (hazard ratio [HR] 1.75 [95% CI 1.53, 2.00]) and achieved SBP <140 mmHg (HR 1.67 [95% CI 1.46, 1.90]). There was a significant reduction in CVD risk in patients <65 years (HR 0.81 [95% CI 0.69, 0.96]) but no difference for other patients, including patients >= 65 years, who achieved SBP <130 mmHg when compared with the group that achieved SBP <140 mmHg. CONCLUSIONS Our findings support a SBP treatment target of 140 mmHg and suspect no risk reduction attenuation on CVD for lower SBP targets (<120 or <130 mmHg) for most patients with uncomplicated T2DM. A randomized control trial is still needed to confirm these findings.
引用
收藏
页码:1134 / 1141
页数:8
相关论文
共 58 条
[1]   Blood pressure targets: are clinical guidelines wrong? [J].
Agustin Arguedas, Jose .
CURRENT OPINION IN CARDIOLOGY, 2010, 25 (04) :350-354
[2]  
American Diabetes Association, 2018, DIABETES CARE S1, V38, pS86
[4]   Global Guideline for Type 2 Diabetes [J].
不详 .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 104 (01) :1-52
[5]  
[Anonymous], 2015, IDF Diabetes Atlas, V7
[6]   The Implications of Blood Pressure Measurement Methods on Treatment Targets for Blood Pressure [J].
Bakris, George L. .
CIRCULATION, 2016, 134 (13) :904-905
[7]   An Expert Opinion From the European Society of Hypertension-European Union Geriatric Medicine Society Working Group on the Management of Hypertension in Very Old, Frail Subjects [J].
Benetos, Athanase ;
Bulpitt, Christopher J. ;
Petrovic, Mirko ;
Ungar, Andrea ;
Rosei, Enrico Agabiti ;
Cherubini, Antonio ;
Redon, Josep ;
Grodzicki, Tomasz ;
Dominiczak, Anna ;
Strandberg, Timo ;
Mancia, Giuseppe .
HYPERTENSION, 2016, 67 (05) :820-825
[8]   Polypharmacy in the Aging Patient Management of Hypertension in Octogenarians [J].
Benetos, Athanase ;
Rossignol, Patrick ;
Cherubini, Antonio ;
Joly, Laure ;
Grodzicki, Tomasz ;
Rajkumar, Chakravarthi ;
Strandberg, Timo E. ;
Petrovic, Mirko .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (02) :170-180
[9]  
Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI [10.1161/CIR.0000000000000558, 10.1161/CIR.0000000000000485, 10.1161/CIR.0000000000000530]
[10]   A comparison of observational studies and randomized, controlled trials. [J].
Benson, K ;
Hartz, AJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (25) :1878-1886